These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

929 related articles for article (PubMed ID: 10419542)

  • 1. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
    Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
    Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) of responses to nitric oxide-donors in rat pulmonary artery: influence of the mechanism of nitric oxide generation.
    Homer KL; Fiore SA; Wanstall JC
    J Pharm Pharmacol; 1999 Feb; 51(2):135-9. PubMed ID: 10217311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.
    Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E
    Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
    Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of soluble guanylate cyclase in dilator responses of the cerebral microcirculation.
    Faraci FM; Sobey CG
    Brain Res; 1999 Mar; 821(2):368-73. PubMed ID: 10064823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
    Homer KL; Wanstall JC
    Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.
    Moro MA; Russel RJ; Cellek S; Lizasoain I; Su Y; Darley-Usmar VM; Radomski MW; Moncada S
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1480-5. PubMed ID: 8643658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles.
    Sobey CG; Faraci FM
    Stroke; 1997 Apr; 28(4):837-42; discussion 842-3. PubMed ID: 9099205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the vasorelaxant effects of 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole (YC-1) and diethylamine/nitric oxide (DEA/NO) on the human radial artery used as coronary bypass graft.
    Berkan O; Bagcivan I; Kaya T; Yildirim K; Yildirim S; Doğan K
    Can J Physiol Pharmacol; 2007 May; 85(5):521-6. PubMed ID: 17632587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation.
    Tseng CM; Tabrizi-Fard MA; Fung HL
    J Pharmacol Exp Ther; 2000 Feb; 292(2):737-42. PubMed ID: 10640313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
    Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide.
    Onoue H; Katusic ZS
    Brain Res; 1998 Feb; 785(1):107-13. PubMed ID: 9526059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
    Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
    Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a novel guanylyl cyclase inhibitor on the vascular actions of nitric oxide and peroxynitrite in immunostimulated smooth muscle cells and in endotoxic shock.
    Zingarelli B; Haskó G; Salzman AL; Szabó C
    Crit Care Med; 1999 Sep; 27(9):1701-7. PubMed ID: 10507586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
    Schrammel A; Behrends S; Schmidt K; Koesling D; Mayer B
    Mol Pharmacol; 1996 Jul; 50(1):1-5. PubMed ID: 8700100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes.
    Wegener JW; Closs EI; Förstermann U; Nawrath H
    Br J Pharmacol; 1999 Jun; 127(3):693-700. PubMed ID: 10401560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lignan (-)-cubebin inhibits vascular contraction and induces relaxation via nitric oxide activation in isolated rat aorta.
    Carvalho MT; Rezende KC; Evora PR; Bastos JK; Cunha WR; Andrade E Silva ML; Celotto AC
    Phytother Res; 2013 Dec; 27(12):1784-9. PubMed ID: 23401173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
    Fedele E; Jin Y; Varnier G; Raiteri M
    Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular nitric oxide release mediates soluble guanylate cyclase-independent vasodilator action of spermine NONOate: comparison with other nitric oxide donors in isolated rat femoral arteries.
    Miller MR; Okubo K; Roseberry MJ; Webb DJ; Megson IL
    J Cardiovasc Pharmacol; 2004 Mar; 43(3):440-51. PubMed ID: 15076229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
    Bouallegue A; Daou GB; Srivastava AK
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.